TMCnet News
Research and Markets: Left Ventricular Dysfunction - Pipeline Review, H2 2013 Research ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/8b8qpq/left_ventricular) has announced the addition of the "Left Ventricular Dysfunction - Pipeline Review, H2 2013" report to their offering. 'Left Ventricular Dysfunction - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Left Ventricular Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Left Ventricular Dysfunction. Scope - A snapshot of the global therapeutic scenario for Left Ventricular Dysfunction. - A review of the Left Ventricular Dysfunction products under development by companies and universities/research institutes based on information derived from company and industry-speific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Left Ventricular Dysfunction pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: List of Tables List of Figures Introduction Left Ventricular Dysfunction Overview Therapeutics Development Pipeline Products for Left Ventricular Dysfunction - Overview Pipeline Products for Left Ventricular Dysfunction - Comparative Analysis Late Stage Products Clinical Stage Products Early Stage Products Assessment by Monotherapy Products Drug Profiles carvedilol CR - Drug Profile carvedilol CR - Drug Profile omecamtiv mecarbil - Drug Profile bromocriptine - Drug Profile CAP-1002 - Drug Profile cimaglermin alfa - Drug Profile CPI-003 - Drug Profile DIOHF - Drug Profile carvedilol CR - Drug Profile Product Description Mechanism of Action R&D Progress Featured News & Press Releases Companies Mentioned Amgen Inc. Acorda Therapeutics, Inc. Innopharmax Inc. RedHill Biopharma Ltd. Capricor Therapeutics, Inc. For more information visit http://www.researchandmarkets.com/research/8b8qpq/left_ventricular About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
